Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Empower Clinics’ (CBDT) COVID-19 testing solutions offered at the Port of Vancouver and Canada Place processed more than 4000 tests in July
  • All the company’s COVID-19 testing solutions are fully accredited by the College of Physicians and Surgeons of BC’s Diagnostic Accreditation Program (DAP)
  • Empower Clinics is an integrated healthcare company serving patients through medical centers, telemedicine platforms, a medical device company, and a high-complexity medical diagnostics laboratory
  • Empower Clinics Inc’s (CBDT) stock price remains unchanged at $0.05 per share at 11:02 am EDT

Empower Clinics’ (CBDT) COVID-19 testing solutions offered at the Port of Vancouver and Canada Place processed more than 4000 tests in July.

The company also has more than 600 appointments confirmed for the remainder of the cruise season.

Steven McAuley, Chairman and CEO of Empower Clinics, commented on the news.

Photo courtesy Empower Clinics Inc

“More than half way into this year’s cruise season, we’re proud to have the cruise industry standing behind our fully accredited COVID-19 testing solutions in Vancouver. I’m grateful and proud of our entire team who continually deliver excellent, reliable, and convenient testing solutions. The feedback from cruise line companies and their passengers has been very positive throughout the season. We remain ready to serve for the rest of the season and anticipate continued strong volumes for August and September.”

While the cruise season in Vancouver runs until November, the peak season runs from July to October based on cruise schedules managed by the Port of Vancouver.

With several ships carrying more than 4000 people, the Vancouver Fraser Port Authority expects more than 300 cruise ship calls for the 2022 season – a nearly eight per cent increase from 288 calls in pre-pandemic 2019.

All of Empower’s COVID-19 testing solutions are fully accredited by the College of Physicians and Surgeons of British Columbia’s Diagnostic Accreditation Program (DAP).

Passengers can visit www.empowerclinics.com/covid-19-testing to book COVID-19 testing solutions that include virtual (telehealth) or in-person Rapid Antigen / Rapid PCR (RT-Lamp) testing at a site at Fairmont Waterfront Hotel – adjacent to the port terminal at Canada Place in Vancouver.

Empower Clinics Inc’s (CBDT) stock price remains unchanged at $0.05 per share at 11:02 am EDT.


More From The Market Herald
Small Pharma - CEO, George Tziras.

" Small Pharma (TSXV:DMT) announces NCIB

Small Pharma (DMT) has received TSXV approval for a normal course issuer bid.
Spectral Medical Inc. - CMO, Dr. John Kellum

" Spectral (TSX:EDT) gets FDA approval for Tigris trial

Spectral Medical (EDT) announced that the U.S. Food and Drug Administration (FDA) has approved ten new clinical trial sites for the Tigris trial.

" Diagnos (TSXV:ADK) receives approval for its AI enabled Pathology Detection Systems

Diagnos (ADK) has received approval from the Costa Rican regulatory agency for its Artificial Intelligence (AI) enabled Pathology Detection Systems.

" BioHarvest (CSE:BHSC) launches first major U.S marketing campaign

BioHarvest Sciences (BHSC) has announced the first multimedia campaign for VINIA in the USA, Phase 1.